Orthopox Virus Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Orthopox Virus Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Orthopox Virus Infection trials you may qualify for* To provide a therapeutic option for patients not able to take the oral formulation of TPOXX (e.g., cannot swallow, vomiting) and who have confirmed or suspect…
The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.
The goal of this clinical trial is to evaluate whether both Form H and Form II, 100mg brincidofovir tablets are bioequivalent, when given under fasting conditio…
The purpose of this study is to follow responses to treatment with vaccinia immune globulin (VIG) for safety and clinical benefit \[during HIV vaccine research\…
The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of two clinical doses of the anti-orthopoxvirus drug, ST-246, administere…